Recently, the Category 2.2 moidfied new traditional Chinese medicine Children's Chiqiao Qingre Syrup of Jumpcan Pharmaceutical Group Co., Ltd. is approved for marketing by China NMPA. It is a pediatric drug with highly increased compliance after the modification of dosage form.

This drug is to dispel wind and release the exterior, clear heat and promote stagnation, and is suitable for children with wind heat and cold stagnation syndrome. Indications include fever, cough, nasal congestion and runny nose, sore throat, anorexia and thirst, bloating in the epigastric region, constipation or sour and foul smelling stool, and deep-colored urine. The marketing of this drug provides new treatment choice for children with wind heat and cold stagnation syndrome.